The serum levels of soluble CD163, which is a biomarker of activated macrophages, are elevated in patients with AIH compared with HCs, and sustained elevation of soluble CD163 is associated with an incomplete response to treatment.41 Here, CD163 is linked to autoimmune hepatitis.